Read More 1 minute read Analyst Ratings Downgrades News Price Target Citigroup Downgrades Atara Biotherapeutics to Sell, Announces $3 Price Target By Benzinga Newsdesk July 20, 6:19 AM Citigroup analyst Yigal Nochomovitz downgrades Atara Biotherapeutics (NASDAQ:ATRA) from Neutral to Sell and announces $3 price target. ATRA
Read More 1 minute read Analyst Ratings News Price Target Upgrades Stifel Upgrades Netflix to Buy, Raises Price Target to $250 By Benzinga Newsdesk July 20, 6:17 AM Stifel analyst Scott Devitt upgrades Netflix (NASDAQ:NFLX) from Hold to Buy and raises the price target from $240 to $250. NFLX
Read More 1 minute read Analyst Ratings News Price Target Upgrades Keybanc Upgrades FMC to Overweight, Announces $122 Price Target By Benzinga Newsdesk July 20, 6:14 AM Keybanc analyst Aleksey Yefremov upgrades FMC (NYSE:FMC) from Sector Weight to Overweight and announces $122 price target. FMC
Read More 1 minute read Analyst Ratings News Price Target HC Wainwright & Co. Maintains Buy on Genmab, Raises Price Target to $49 By Benzinga Newsdesk July 20, 6:13 AM HC Wainwright & Co. analyst Raghuram Selvaraju maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $47 to $49. GMAB
Read More 1 minute read Analyst Ratings News Price Target Upgrades Bernstein Upgrades Alibaba Group Holding to Outperform, Raises Price Target to $130 By Benzinga Newsdesk July 20, 6:01 AM Bernstein analyst Robin Zhu upgrades Alibaba Group Holding (NYSE:BABA) from Market Perform to Outperform and raises the price target from $115 to $130. BABA
Read More 1 minute read Analyst Ratings Downgrades News Price Target Evercore ISI Group Downgrades Ally Financial to In-Line, Announces $36 Price Target By Benzinga Newsdesk July 20, 5:53 AM Evercore ISI Group analyst John Pancari downgrades Ally Financial (NYSE:ALLY) from Outperform to In-Line and announces $36 price target. ALLY
Read More 1 minute read Analyst Ratings Initiation News Price Target Oppenheimer Initiates Coverage On Lumos Pharma with Outperform Rating, Announces Price Target of $20 By Benzinga Newsdesk July 20, 5:50 AM Oppenheimer analyst Leland Gershell initiates coverage on Lumos Pharma (NASDAQ:LUMO) with a Outperform rating and announces Price Target of $20. LUMO
Read More 1 minute read Analyst Ratings Initiation News Price Target Stephens & Co. Initiates Coverage On Landec with Overweight Rating, Announces Price Target of $13 By Benzinga Newsdesk July 20, 5:45 AM Stephens & Co. analyst Jacob Johnson initiates coverage on Landec (NASDAQ:LNDC) with a Overweight rating and announces Price Target of $13. LNDC
Read More 1 minute read Analyst Ratings Downgrades News Price Target Credit Suisse Downgrades Sealed Air to Neutral, Lowers Price Target to $64 By Benzinga Newsdesk July 20, 5:43 AM Credit Suisse analyst Curt Woodworth downgrades Sealed Air (NYSE:SEE) from Outperform to Neutral and lowers the price target from $80 to $64. SEE
Read More 1 minute read Analyst Ratings Initiation News Price Target MKM Partners Initiates Coverage On Viper Energy Partners with Buy Rating, Announces Price Target of $31 By Benzinga Newsdesk July 20, 5:41 AM MKM Partners analyst Leo Mariani initiates coverage on Viper Energy Partners (NASDAQ:VNOM) with a Buy rating and announces Price Target of $31. VNOM